Healthtech Startups

Genomadix develops the Cube, a point-of-care PCR platform for real-time molecular testing in precision medicine and environmental applications. The company commercializes FDA-cleared genotyping tests and offers its open platform for partnerships with assay developers and clinical laboratories.

1 investor

Genomate Health develops an AI-powered clinical decision support system for precision oncology that analyzes a patient's molecular profile to produce evidence-based treatment rankings for physicians. Its Genomate platform combines oncology, genomics, and computational reasoning to support personalized cancer treatment decisions.

1 investor

Genome Biologics operates a contract research service using TrueCardium, an iPSC-derived multicellular human cardiac organoid platform, to run cardiotoxicity screening, disease modeling, and drug efficacy studies. It serves pharmaceutical and biotechnology partners seeking human-relevant cardiac safety and translational data beyond conventional 2D assays and animal models.

1 investor

GenoME Diagnostics develops PCR-based diagnostic and biomarker technologies for cancer, with research programmes in ovarian and pancreatic cancer. The company builds on cancer biomarker and DNA methylation research from its academic founders.

1 investor

1 investor

GenomILL develops precision diagnostic technologies using genomic analysis. The company serves clinical and research customers seeking advanced molecular diagnostics.

1 investor

GenMedPro is a genetics-based medication management platform that analyzes 26 genes to identify drug-drug and gene-drug interactions across a patient's entire medication regimen. The platform serves healthcare providers and care teams to reduce prescribing errors, prevent adverse events, and optimize medication safety for complex polypharmacy cases.

1 investor

GenomSys develops modular software for storing, processing and sharing genomic data based on the ISO/IEC 23092 MPEG-G standard, serving diagnostic laboratories, hospitals, research centers and biotech companies. The company operates in computational genomics and precision medicine, with a Swiss parent company and an Italian subsidiary running its MPEG-G Competence Center in Milan.

1 investor

Genomtec develops a mobile platform for point-of-care genetic diagnostics that detects respiratory pathogens including viruses and bacteria. The company has obtained CE-IVD certification for its respiratory diagnostic panel in Europe.

1 investor

Genotix Bio develops the DaVinci, a compact nanoarray analyzer that detects proteins and nucleic acids at single-molecule resolution for research applications. The instrument enables ultrasensitive biomarker detection with minimal sample volumes and fast processing times.

1 investor

Genova Diagnostics operates a clinical laboratory offering functional-medicine diagnostic tests, including gut microbiome, metabolomics, methylation, genomics, and oxidative stress panels. Its testing combines multiple technologies, including whole-genome shotgun sequencing with AI-based analysis, to help clinicians assess gut health and other physiological systems for personalized patient care.

1 investor

GenScript Biotech is a life sciences company providing reagents, custom services, instruments, and biologics development solutions to research and pharmaceutical industries globally. The company operates through subsidiaries including Bestzyme (synthetic biology), ProBio (biologics CDMO), and GenScript Life Science Group, with manufacturing and R&D centers across China, Singapore, and the United States.

1 investor

Gentle manufactures a personalized neurotech headband that delivers safe, non-invasive neurostimulation to help users manage anxiety, improve focus, and enhance sleep quality. The device is paired with a mobile app that learns from user sessions and personalizes protocols for mental health and wellness.

1 investor

GentleFoods produces texture-modified, ready-to-eat meals (IDDSI levels L3–L6) for people with swallowing difficulties (dysphagia), using moulded puréed versions of local Asian dishes. The products are sold in Singapore through hospital pharmacies and retail locations for patients and caregivers.

1 investor

Gently Soap is a bar soap brand formulated with medicinal plants and botanicals grown by U.S. farmers, designed for people with sensitive skin conditions like eczema. The company prioritizes plastic-free, natural skincare products and sustainability.

1 investor

Genuity Science provides genomics research services—including study design, cohort sourcing, sample preparation, whole genome sequencing, and advanced analytics—along with disease-specific clinico-omic datasets. It serves drug discovery clients working on CNS, cardiometabolic, and inflammatory diseases to support target and biomarker programs.

1 investor

GenWorks manufactures medical devices for patient monitoring and care support across ICU, critical care, operating theater, and maternal-newborn care settings. The company produces infusion pumps, defibrillators, anesthesia machines, ventilators, and related monitoring equipment for hospitals and healthcare facilities.

1 investor

George Medicines develops single-pill combination therapies for cardiometabolic diseases such as hypertension and diabetes, leveraging research from The George Institute for Global Health. The company targets patients with low medication adherence and aims to reduce the burden of non-communicable diseases on patients, families, and health systems.

1 investor

The Georgia Research Alliance is a nonprofit that supports university research and entrepreneurship across Georgia by funding scientists, backing research infrastructure, and helping launch and grow companies based on university inventions. It works with Georgia's research universities and their researchers to commercialize discoveries in fields such as healthcare and materials.

1 investor

Germfree provides cleanroom and biocontainment facility solutions for pharmaceutical, pharmacy, and biopharma manufacturing, leveraging over 60 years of experience and in-house fabrication technology. The company serves life science organizations developing medicines and conducting research requiring controlled laboratory environments.

1 investor

Germitec develops UV-C technology-based disinfection systems for high-level decontamination of ultrasound probes and other medical devices used in healthcare settings. The company serves healthcare professionals and institutions seeking to prevent healthcare-associated infections while maintaining regulatory compliance and traceability.

1 investor

Gestala develops ultrasound-based brain-computer interfaces aimed at whole-brain read and write capabilities, targeting treatment of neurological disorders such as chronic pain, stroke rehabilitation, and PTSD. The Chinese company also works on decoding the brain and exploring the convergence of neuroscience and artificial intelligence.

1 investor

GestSure makes a sensor-based system that lets surgeons navigate MRI and CT imaging in the operating room through hand gestures, avoiding the need to touch a non-sterile keyboard or mouse. The device functions as a standard USB input, works with existing medical imaging viewers, and is aimed at surgical and hospital OR settings.

1 investor

A Japanese health company offering at-home fertility and menopause assessment services for women, including tests for women's fertility status, menopause markers, and AMH levels.

1 investor